Inventor · disambiguated record
Riccardo Giovannini
Also filed as: GIOVANNINI RICCARDO
65 granted patents·19 pending applications·311 citations·filing 2000–2025
98Inventor score
Files withBOEHRINGER INGELHEIM INT27EBEL HEINER12GIOVANNINI RICCARDO10CENTREXION THERAPEUTICS CORP8ALVARO GIUSEPPE6
Top patents by PatentIndex Score
84 records- 0191US11046706B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Jun 29, 2021·3 cites·26 claims
- 0291US10196402B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Feb 5, 2019·7 cites·31 claims
- 0391US9067951B2Process and intermediates for the production of CCR2 antagonistsEBEL HEINER·Filed 2014·Granted Jun 30, 2015·20 cites·9 claims
- 0491US8653075B2Therapeutic methods employing substituted piperidines which are CCR3 antagonistsGRUNDL MARC·Filed 2012·Granted Feb 18, 2014·20 cites·66 claims
- 0591US8278302B2Substituted piperidines as CCR3 antagonistsGRUNDL MARC·Filed 2010·Granted Oct 2, 2012·21 cites·45 claims
- 0691US6642240B2Treating emesis in a mammalSMITHKLINE BEECHAM CORP·Filed 2002·Granted Nov 4, 2003·31 cites·31 claims
- 0790US7655693B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Feb 2, 2010·14 cites·14 claims
- 0889US11731981B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2021·Granted Aug 22, 2023·1 cites·20 claims
- 0989US10875867B2Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamideBOEHRINGER INGELHEIM INT·Filed 2019·Granted Dec 29, 2020·3 cites·13 claims
- 1089US9670222B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2014·Granted Jun 6, 2017·9 cites·23 claims
- 1188US8765949B2CCR2 receptor antagonists and uses thereofEBEL HEINER·Filed 2010·Granted Jul 1, 2014·9 cites·39 claims
- 1288US7855218B2CompoundsCONVERGENCE PHARMACEUTICALS·Filed 2006·Granted Dec 21, 2010·13 cites·16 claims
- 1387US8153681B2Method of treating epilepsy by administering 5-(4{[(2-fluorophenyl)methyl]oxy}phenyl)prolinamideALVARO GIUSEPPE·Filed 2009·Granted Apr 10, 2012·9 cites·8 claims
- 1486US12209094B2CCR2 receptor antagonists and uses thereofCENTREXION THERAPEUTICS CORP·Filed 2023·Granted Jan 28, 2025·0 cites·20 claims
- 1586US10640486B2Heteroarylcarboxamide derivatives as plasma kallikrein inhibitorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted May 5, 2020·4 cites·13 claims
- 1686US9789082B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2016·Granted Oct 17, 2017·5 cites·38 claims
- 1786US8835440B2Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPDEBEL HEINER·Filed 2013·Granted Sep 16, 2014·9 cites·15 claims
- 1885US10675268B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2018·Granted Jun 9, 2020·2 cites·15 claims
- 1985US10166214B2Somatostatin receptor subtype 4 (SSTR4) agonistsCENTREXION THERAPEUTICS CORP·Filed 2017·Granted Jan 1, 2019·4 cites·25 claims
- 2085US8962656B2CCR2 antagonistsEBEL HEINER·Filed 2011·Granted Feb 24, 2015·9 cites·15 claims
- 2185US8841313B2CCR2 antagonists and uses thereofEBEL HEINER·Filed 2011·Granted Sep 23, 2014·9 cites·21 claims
- 2284US12351584B2Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamideBOEHRINGER INGELHEIM INT·Filed 2023·Granted Jul 8, 2025·0 cites·13 claims
- 2384US10479794B2Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamideBOEHRINGER INGELHEIM INT·Filed 2018·Granted Nov 19, 2019·3 cites·73 claims
- 2484US8143306B2Methods of treating bipolar disordersALVARO GIUSEPPE·Filed 2011·Granted Mar 27, 2012·8 cites·12 claims
- 2583US9371282B2Somatostatin receptor subtype 4 (SSTR4) agonistsCT XION THERAPEUTICS CORP·Filed 2014·Granted Jun 21, 2016·8 cites·48 claims
- 2682US10399961B2Heteroarylcarboxamide derivatives as plasma kallikrein inhibitorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Sep 3, 2019·4 cites·12 claims
- 2782USRE45323ESubstituted piperidines as CCR3 antagonistsGRUNDL MARC·Filed 2014·Granted Jan 6, 2015·5 cites·45 claims
- 2882US8648085B21, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disordersEICKMEIER CHRISTIAN·Filed 2008·Granted Feb 11, 2014·8 cites·9 claims
- 2982US8623879B21-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivates and their use as PDE9A modulatorsGIOVANNINI RICCARDO·Filed 2009·Granted Jan 7, 2014·5 cites·39 claims
- 3080US9102679B2Compounds for the treatment of CNS disordersGIOVANNINI RICCARDO·Filed 2013·Granted Aug 11, 2015·5 cites·5 claims
- 3180US6951861B1Chemical compoundsSMITHKLINE BEECHAN CORP·Filed 2000·Granted Oct 4, 2005·15 cites·102 claims
- 3279US10849907B2Imidazopyridine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 1, 2020·1 cites·49 claims
- 3379US7345041B2Chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2006·Granted Mar 18, 2008·2 cites·3 claims
- 3478US10071974B2Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonistsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Sep 11, 2018·2 cites·25 claims
- 3578US9108958B2Selective CCR2 antagonistsEBEL HEINER·Filed 2012·Granted Aug 18, 2015·4 cites·13 claims
- 3678US8912201B26-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disordersHEINE NIKLAS·Filed 2011·Granted Dec 16, 2014·4 cites·25 claims
- 3777US9096603B21-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A modulatorsGIOVANNINI RICCARDO·Filed 2013·Granted Aug 4, 2015·3 cites·4 claims
- 3877US9085584B2Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disordersGIOVANNINI RICCARDO·Filed 2013·Granted Jul 21, 2015·5 cites·34 claims
- 3976US10183940B2Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonistsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jan 22, 2019·2 cites·15 claims
- 4076US8623901B2Compounds for the treatment of CNS disordersGIOVANNINI RICCARDO·Filed 2010·Granted Jan 7, 2014·3 cites·22 claims
- 4175US10577336B2Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonistsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Mar 3, 2020·1 cites·12 claims
- 4275US10023575B2Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamideBOEHRINGER INGELHEIM INT·Filed 2016·Granted Jul 17, 2018·1 cites·75 claims
- 4374US9328120B26-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disordersHEINE NIKLAS·Filed 2014·Granted May 3, 2016·2 cites·19 claims
- 4474US9079905B2Compounds for the treatment of CNS disordersFUCHS KLAUS·Filed 2009·Granted Jul 14, 2015·2 cites·4 claims
- 4572US11691977B2Cyclic ether derivatives of pyrazolo[1,5-A]pyrimidine-3-carboxyamideBOEHRINGER INGELHEIM INT·Filed 2020·Granted Jul 4, 2023·0 cites·15 claims
- 4672US9012489B2Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicamentGIOVANNINI RICCARDO·Filed 2012·Granted Apr 21, 2015·2 cites·47 claims
- 4772US8877745B2CCR2 receptor antagonists, method for producing the same, and use thereof as medicamentsEBEL HEINER·Filed 2011·Granted Nov 4, 2014·2 cites·11 claims
- 4872US8809345B26-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disordersHEINE NIKLAS·Filed 2012·Granted Aug 19, 2014·2 cites·13 claims
- 4971US11166958B24-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2019·Granted Nov 9, 2021·0 cites·31 claims
- 5070US9029544B2Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparationWAGNER HOLGER·Filed 2011·Granted May 12, 2015·2 cites·15 claims
Showing the top 50 of 84 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →